V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20198311 | 20152912 | 1.61 | 46.7 | Adjuvant (A) | 2016-02-04 | 2016-07-06 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101040506 |
| 20198313 | 20152913 | 1.67 | 98 | Palliative (P) | 2016-07-13 | 2017-11-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101405981 |
| 20198317 | 20152914 | 1.87 | 81 | Palliative (P) | 2017-08-06 | 2017-10-30 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101296501 |
| 20198318 | 20152915 | 1.87 | 59 | Adjuvant (A) | 2018-08-19 | 2018-10-06 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100919422 |
| 20198325 | 20152916 | 1.76 | 62 | Palliative (P) | 2020-02-15 | 2020-02-21 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101209439 |
| 20198326 | 20152917 | 1.66 | 63.7 | Palliative (P) | 2020-11-03 | 2020-11-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101294907 |
| 20198327 | 20152918 | 1.81 | 72.5 | Palliative (P) | 2020-07-23 | 2020-11-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101450186 |
| 20198333 | 20152919 | 1.49 | 95 | 03 | 2016-11-01 | 2016-11-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101337586 |
| 20198334 | 20152920 | 1.84 | 65.9 | Palliative (P) | 2018-12-28 | 2018-12-30 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101163223 |
| 20198353 | 20152921 | 1.63 | 83.75 | null | 2018-12-27 | 2019-05-07 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100417368 |
| 20198358 | 20152922 | 1.83 | 63.2 | null | 2016-11-16 | 2016-11-18 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101817985 |
| 20198361 | 20152923 | 1.74 | 98 | Curative (C) | 2019-10-28 | 2019-10-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100041357 |
| 20198362 | 20152924 | 1.59 | 69 | null | 2018-06-04 | 2018-06-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101623366 |
| 20198367 | 20152925 | 1.76 | 70.1 | Palliative (P) | 2022-05-18 | 2022-05-22 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101405118 |
| 20198369 | 20152926 | 1.74 | 63 | Palliative (P) | 2016-09-26 | 2016-10-01 | Docetaxel | 02 | N | DOCETAXEL | 101467224 |
| 20198372 | 20152927 | 1.85 | 73 | Palliative (P) | 2020-08-10 | 2020-08-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101185282 |
| 20198379 | 20152928 | null | 72.8 | null | 2018-10-12 | 2019-01-07 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101133157 |
| 20198381 | 20152929 | 1.82 | 81.5 | null | 2017-05-27 | 2017-06-15 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101542818 |
| 20198384 | 20152930 | 1.86 | 60 | Palliative (P) | 2017-10-25 | 2017-11-09 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100986303 |
| 20198386 | 20152931 | 1.6 | 77.65 | Adjuvant (A) | 2017-06-10 | 2017-06-23 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100846064 |
| 20198390 | 20152932 | 1.76 | 78 | null | 2017-04-28 | 2017-05-13 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101598680 |
| 20198401 | 20152933 | 1.69 | 82.6 | Palliative (P) | 2018-01-03 | 2018-01-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101412154 |
| 20198412 | 20152934 | 1.7 | 85 | Palliative (P) | 2019-01-08 | 2019-01-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100339130 |
| 20198415 | 20152935 | 1.81 | 88.9 | Palliative (P) | 2018-05-06 | 2018-06-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101749489 |
| 20198416 | 20152936 | 1.6 | 56.3 | null | 2017-06-07 | 2017-06-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101343387 |
| 20198417 | 20152937 | 1.78 | 86.8 | Palliative (P) | 2022-03-14 | 2022-03-29 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101374712 |
| 20198430 | 20152938 | 1.98 | 102 | null | 2019-02-16 | 2019-02-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100606636 |
| 20198431 | 20152939 | 1.59 | 102 | Palliative (P) | 2017-09-16 | 2018-01-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101169050 |
| 20198433 | 20152940 | 1.67 | 65.5 | Palliative (P) | 2019-05-14 | 2019-08-12 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100781363 |
| 20198435 | 20152941 | 1.54 | 79.5 | null | 2020-03-08 | 2020-03-29 | Docetaxel | 02 | null | DOCETAXEL | 101041762 |
| 20198437 | 20152942 | 1.82 | 46.4 | null | 2018-06-25 | 2018-07-18 | Docetaxel | 02 | null | DOCETAXEL | 100462396 |
| 20198439 | 20152943 | 1.76 | 56.5 | Palliative (P) | 2017-03-02 | 2017-03-18 | Cetuximab + FOLFIRI cycle1 | 02 | N | CAPECITABINE + GEMCITABINE | 101344421 |
| 20198441 | 20152944 | 1.74 | 77 | Palliative (P) | 2016-05-24 | 2016-06-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101175978 |
| 20198442 | 20152945 | 1.62 | 63.2 | null | 2019-09-18 | 2019-09-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100413526 |
| 20198447 | 20152946 | 1.74 | 65.9 | Palliative (P) | 2020-11-25 | 2020-11-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101569920 |
| 20198448 | 20152947 | 1.65 | 72 | Palliative (P) | 2018-09-13 | 2019-08-11 | Cetuximab + FOLFIRI cycle1 | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100940188 |
| 20198454 | 20152948 | 1.76 | 73.4 | Palliative (P) | 2017-07-01 | 2017-07-12 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101022546 |
| 20198456 | 20152949 | 1.74 | 68.5 | Palliative (P) | 2019-01-10 | 2019-02-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100509952 |
| 20198463 | 20152950 | 1.63 | 65.5 | Adjuvant (A) | 2015-12-27 | 2016-03-07 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100216119 |
| 20198469 | 20152951 | 1.74 | 98 | Palliative (P) | 2019-11-19 | 2019-11-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101383798 |
| 20198471 | 20152952 | 1.76 | 68.2 | Palliative (P) | 2017-08-01 | 2018-10-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101487229 |
| 20198473 | 20152953 | 1.7 | 83 | Adjuvant (A) | 2017-03-18 | 2017-04-06 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101537013 |
| 20198475 | 20152954 | 1.68 | 72.6 | Palliative (P) | 2020-04-22 | 2020-06-17 | Docetaxel | 02 | N | DOCETAXEL | 101064561 |
| 20198484 | 20152955 | 1.51 | 92.7 | Palliative (P) | 2022-03-05 | 2022-05-29 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101541226 |
| 20198489 | 20152956 | 1.59 | 64 | Palliative (P) | 2019-11-09 | 2019-11-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101193582 |
| 20198496 | 20152957 | 1.74 | 92.7 | null | 2016-08-23 | 2016-09-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 100421012 |
| 20198512 | 20152958 | 1.6 | 78.6 | null | 2019-11-27 | 2019-11-27 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100623618 |
| 20198522 | 20152959 | 1.66 | 81 | Palliative (P) | 2017-01-18 | 2017-01-23 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | DOCETAXEL | 100455471 |
| 20198524 | 20152960 | 1.62 | 48.8 | Palliative (P) | 2020-01-31 | 2020-02-05 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101139493 |
| 20198527 | 20152961 | 1.83 | 49.2 | null | 2018-09-25 | 2018-10-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100677067 |